Cargando…

Clinical application of liquid biopsies to detect somatic BRCA1/2 mutations and guide potential therapeutic intervention for patients with metastatic breast cancer

Plasma based genotyping via cell-free DNA may identify actionable mutations for potential therapeutic intervention in patients with advanced malignancies including breast cancer. In this article, we discuss recent studies using cell-free DNA testing to identify and classify somatic BRCA1/2 mutations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidula, Neelima, Ellisen, Leif W., Bardia, Aditya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825638/ https://www.ncbi.nlm.nih.gov/pubmed/33520111 http://dx.doi.org/10.18632/oncotarget.27863

Ejemplares similares

Novel antibody–drug conjugates for triple negative breast cancer
por: Nagayama, Aiko, et al.
Publicado: (2020)

Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer
por: Vidula, Neelima, et al.
Publicado: (2023)

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
por: Vidula, Neelima, et al.
Publicado: (2017)

A microRNA-dependent circuit controlling p63/p73 homeostasis: p53 family cross-talk meets therapeutic opportunity
por: Ory, Benjamin, et al.
Publicado: (2011)

New perspective on maintenance therapies for platinum- sensitive recurrent ovarian cancer in women with germline and somatic mutations in BRCA1 and BRCA2 genes
por: Vergote, I, et al.
Publicado: (2016)

Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
por: Medford, Arielle J., et al.
Publicado: (2019)

Olaparib and somatic BRCA mutations
por: George, Angela, et al.
Publicado: (2017)

Redefining precision radiotherapy through liquid biopsy
por: McLaren, D. B., et al.
Publicado: (2023)

Liquid biopsy in lymphoma
por: Rossi, Davide, et al.
Publicado: (2019)

Liquid Biopsy: Emergence of an Alternative Cancer Detection Method
por: Law, Ethan W., et al.
Publicado: (2020)

BRCA1 reversion mutation acquired after treatment identified by liquid biopsy
por: Mayor, Paul, et al.
Publicado: (2017)

Mechanisms of Resistance to Antibody–Drug Conjugates
por: Abelman, Rachel Occhiogrosso, et al.
Publicado: (2023)

DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers
por: Suba, Zsuzsanna
Publicado: (2015)

Epistatic Relationships in the BRCA1-BRCA2 Pathway
por: Scully, Ralph
Publicado: (2011)

Brain somatic mutations in MTOR leading to focal cortical dysplasia
por: Lim, Jae Seok, et al.
Publicado: (2016)

Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
por: Farncombe, Kirsten M., et al.
Publicado: (2023)

BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer
por: Kondo, Tomohiro, et al.
Publicado: (2020)

Cognitive Computing to Guide Molecular‐Based Therapy Selection: Steps Forward amid Abundant Need
por: Ellisen, Leif W.
Publicado: (2018)

Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases
por: Febbo, Phillip G., et al.
Publicado: (2020)

Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer
por: Miller, Philip C., et al.
Publicado: (2019)

Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring
por: Horgan, Denis, et al.
Publicado: (2022)

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
por: Faermann, Renata, et al.
Publicado: (2022)

Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients
por: Zmrzljak, Uršula Prosenc, et al.
Publicado: (2021)

Non-Surgical Cancer Risk Reduction in BRCA1 Mutation Carriers: Disabling the Remote Control
por: Widschwendter, Martin, et al.
Publicado: (2020)

Getting quantitative on the effects of somatic mutation on cancer
por: Townsend, Jeffrey P.
Publicado: (2020)

Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet
por: Ngeow, Joanne, et al.
Publicado: (2016)

Liquid Biopsies Using Plasma Exosomal Nucleic Acids
por: Möhrmann, Lino, et al.
Publicado: (2019)

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer
por: Taniguchi, Fumitaka, et al.
Publicado: (2021)

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer
por: Chen, Bo, et al.
Publicado: (2020)

A novel somatic BRCA2 point mutation in a metastatic pancreatic cancer patient: a case report
por: Wang, Deqiang, et al.
Publicado: (2021)

Olaparib in hormone receptor-positive, HER2-negative metastatic breast cancer with a somatic BRCA2 mutation
por: Schwartzberg, Lee S., et al.
Publicado: (2021)

Efficacy of Olaparib in Treatment-Refractory, Metastatic Breast Cancer with Uncommon Somatic BRCA Mutations Detected in Circulating Tumor DNA
por: Yoon, Jung-Ki, et al.
Publicado: (2023)

Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain
por: Ye, Zimeng, et al.
Publicado: (2021)

Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer
por: Vidula, Neelima, et al.
Publicado: (2022)

Liquid biopsy in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)
por: Palacios, J., et al.
Publicado: (2019)

Evolving insights in blood-based liquid biopsies for prostate cancer interrogation
por: Bonfil, R. Daniel, et al.
Publicado: (2023)

Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
por: Paradiso, Angelo Virgilio, et al.
Publicado: (2020)

Organelle remodeling in somatic cell reprogramming
por: Liu, Yang, et al.
Publicado: (2020)

Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer
por: Spring, Laura M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9iodq88d626js6viv8upjpgp81